Committed to sharing our science

Committed to sharing our science

scientist testing potential medicines

327 results available

Effect of Aficamten on Cardiac Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The SEQUOIA-HCM CMR Trial

Oral Presentation, ESC 2024

Masri A, et al.

London, England

September 1, 2024
Effect of Aficamten on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM

Oral Presentation, ESC 2024

Spertus J, et al.

London, England

September 1, 2024
Cardiac Myosin Inhibitor, CK-586, Minimally Reduces Systolic Function and Ameliorates Obstruction in Feline Hypertrophic Cardiomyopathy

Scientific Reports

Rivas VN, et al.

May 27, 2024
In Vitro and In Vivo Pharmacokinetic Preclinical Characterization of Aficamten, a Small Molecule Cardiac Myosin Inhibitor

Xenobiotica

Sukhun, R et al

August 5, 2024
The Prognostic Value of Peak Oxygen Uptake in Obstructive Hypertrophic Cardiomyopathy: A Literature Review to Inform Economic Model Development

Journal of Medical Economics

Butzner, M et al

July 1, 2024